Bill Janeway - Investing in Life Technologies (webinar)
Please do fill in the quick feedback form here.
What does it take to commence a successful biotechnology start-up? What risks are involved as a private equity investor? How can one manage and offset the risks of cashflow and company control vis-à-vis founders possessing controlling shareholdings? Hear from Dr William H. Janeway, a private equity giant from Warburg Pincus and University of Cambridge, Faculty of Economics lecturer. This is a recording from a live webinar event that took place on 12th June 2020.
Content: During this webinar, Bill discussed the economics of innovation as illustrated by the founding of Life Technologies and resolution of the ‘Biotechnology Paradox’. Bill delved into the risks associated with investing as a private equity investor in this industry and the substantial growth in the number of pharmaceutical and biotechnology IPOs in the US.
Format: Opening remarks were provided by Bill. Pre-submitted questions from our audience were then asked and further questions submitted via the online platform ‘Menti’ were welcomed on the topic.
This event was organised by CUTEC and CUVCPE societies as part of the ongoing ‘CUTalks by CUTEC’ podcast series. The hosts for the webinar were Shreya Singhal and Shelby Newsad. To find other podcast episodes, visit here: https://cutec.io/cutalks. Follow us @CUTEC, #CUTalks and @CUVCPE on LinkedIn, Twitter and Facebook to find out about future events and podcast episodes.
This episode was sponsored by Start Codon. The company identifies and recruits the most disruptive life science and healthcare start-ups worldwide, seed-funds them and leverages the exceptional resources of the Cambridge Cluster to de-risk and drives their success.